tiprankstipranks
Trending News
More News >
Advertisement

RODM - ETF AI Analysis

Compare

Top Page

RODM

Hartford Multifactor Developed Markets (ex-US) ETF (RODM)

Rating:64Neutral
Price Target:
The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) has a solid overall rating, driven by strong contributions from holdings like Novartis AG and Fairfax Financial Holdings. Novartis stands out with its robust profitability, stable balance sheet, and growth in key products, while Fairfax Financial benefits from strong earnings and an attractive valuation. However, weaker performance from holdings like Nokia, which faces profitability and cash flow challenges, slightly offsets the fund's strengths. A key risk factor is the ETF's exposure to overbought conditions in some top holdings, which could lead to short-term volatility.
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as BOC Hong Kong and Toronto Dominion Bank, have delivered strong year-to-date performance, supporting the fund's overall returns.
Global Diversification
The ETF provides exposure to a wide range of developed markets, including Japan, the UK, Canada, and Australia, reducing reliance on any single country.
Low Expense Ratio
With an expense ratio of 0.29%, the ETF is cost-efficient compared to many actively managed funds, helping investors retain more of their returns.
Negative Factors
Underperformance in Recent Months
The ETF's one-month performance has been slightly negative, indicating short-term weakness that investors should monitor.
Sector Concentration in Financials
Financials make up over 22% of the portfolio, which could expose the fund to risks if the sector faces challenges.
Limited U.S. Exposure
The ETF allocates only 14.58% to U.S. companies, which may limit its ability to benefit from strong U.S. market performance.

RODM vs. SPDR S&P 500 ETF (SPY)

RODM Summary

The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) is an investment fund that focuses on stocks from developed countries outside the United States. It includes companies from industries like financials, healthcare, and technology, with top holdings such as Nokia and Roche Holding AG. This ETF uses a multifactor strategy to select stocks based on factors like value and quality, aiming to balance growth potential with risk management. Investors might consider RODM to diversify their portfolios internationally and gain exposure to a wide range of industries and countries. However, new investors should be aware that the ETF’s performance can fluctuate with global market conditions.
How much will it cost me?The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs, as it uses a multifactor strategy to optimize returns and manage risk.
What would affect this ETF?RODM’s focus on developed markets outside the U.S. could benefit from economic recovery or growth in regions like Europe and Asia, particularly in sectors such as financials and healthcare, which have significant weight in the ETF. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in these regions could negatively impact the performance of its top holdings, including companies like Nokia and Roche Holding AG. Additionally, currency fluctuations between the U.S. dollar and foreign currencies may influence returns for U.S.-based investors.

RODM Top 10 Holdings

The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) leans heavily on financials, with names like Toronto Dominion Bank and Royal Bank of Canada showing steady gains and providing a solid foundation for the fund. Health care stocks, such as Roche and GlaxoSmithKline, are rising steadily, driven by strong pipelines and strategic focus on specialty medicines. Meanwhile, industrials like Engie SA are holding their ground but face mixed sentiment due to valuation concerns. With broad exposure across developed markets outside the U.S., the fund balances sector diversity while relying on financials and health care to drive performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Nokia1.41%$18.47M$36.26B45.43%
66
Neutral
Roche Holding AG1.16%$15.26MCHF259.92B52.00%
73
Outperform
Toronto Dominion Bank1.14%$15.01M$158.09B77.36%
74
Outperform
Engie SA1.13%$14.89M€53.49B47.46%
64
Neutral
GlaxoSmithKline1.13%$14.85M$98.80B43.55%
77
Outperform
Royal Bank Of Canada1.08%$14.13M$239.11B41.55%
75
Outperform
BOC Hong Kong (Holdings)1.02%$13.40MHK$412.13B59.46%
78
Outperform
Novartis AG1.00%$13.15MCHF206.92B25.57%
80
Outperform
Fairfax Financial Holdings1.00%$13.10M$43.91B34.48%
81
Outperform
Bank Of Montreal0.98%$12.85MC$126.51B34.58%
74
Outperform

RODM Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.66
Positive
100DMA
35.24
Positive
200DMA
33.54
Positive
Market Momentum
MACD
0.37
Negative
RSI
70.82
Negative
STOCH
34.69
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RODM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.29, equal to the 50-day MA of 35.66, and equal to the 200-day MA of 33.54, indicating a bullish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 70.82 is Negative, neither overbought nor oversold. The STOCH value of 34.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RODM.

RODM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.32B0.29%
$4.85B0.25%
$3.71B0.40%
$3.50B0.30%
$2.87B0.16%
$2.36B0.25%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RODM
Hartford Multifactor Developed Markets (ex-US) ETF
37.11
9.48
34.31%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
LVHI
Legg Mason International Low Volatility High Dividend ETF
IMTM
iShares MSCI Intl Momentum Factor ETF
INTF
iShares MSCI Intl Multifactor ETF
IDMO
Invesco S&P International Developed Momentum ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement